Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify GEOFFREY LING, M.D., PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. | 2021-04-27 | Dr. Ling received a B.S. in Biology and History from Washington University, a Ph.D. in Pharmacology from Cornell University - Graduate School of Medical Sciences and an M.D. from Georgetown University School of Medicine. He co-founded Predigen, Inc., a molecular diagnostics company, and serves as CEO of On Demand Pharmaceuticals, Inc. | Dr. Ling has a Ph.D. in Pharmacology and extensive experience in research, drug development, and as CEO of a molecular diagnostics company, indicating strong technical and scientific expertise that likely includes programming or software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-27 | Dr. Ling received a B.S. in Biology and History from Washington University, a Ph.D. in Pharmacology from Cornell University - Graduate School of Medical Sciences and an M.D. from Georgetown University School of Medicine. He co-founded Predigen, Inc., a molecular diagnostics company, and serves as CEO of On Demand Pharmaceuticals, Inc. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22